LayerRx Mapping ID
733
Slot System
Featured Buckets
Featured Buckets Admin

Using aspirin and ACE inhibitors in combination: Why the hullabaloo?

Article Type
Changed
Fri, 01/25/2019 - 08:30
Display Headline
Using aspirin and ACE inhibitors in combination: Why the hullabaloo?
Article PDF
Author and Disclosure Information

John G. Peterson, MD
Staff cardiologist, Spokane Cardiology, Spokane,WA

Michael S. Lauer, MD
Director of Clinical Research, Department of Cardiology, Cleveland Clinic

Address: Michael S. Lauer, MD, Department of Cardiology, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, [email protected]

Issue
Cleveland Clinic Journal of Medicine - 68(6)
Publications
Topics
Page Number
569-574
Sections
Author and Disclosure Information

John G. Peterson, MD
Staff cardiologist, Spokane Cardiology, Spokane,WA

Michael S. Lauer, MD
Director of Clinical Research, Department of Cardiology, Cleveland Clinic

Address: Michael S. Lauer, MD, Department of Cardiology, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, [email protected]

Author and Disclosure Information

John G. Peterson, MD
Staff cardiologist, Spokane Cardiology, Spokane,WA

Michael S. Lauer, MD
Director of Clinical Research, Department of Cardiology, Cleveland Clinic

Address: Michael S. Lauer, MD, Department of Cardiology, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, [email protected]

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 68(6)
Issue
Cleveland Clinic Journal of Medicine - 68(6)
Page Number
569-574
Page Number
569-574
Publications
Publications
Topics
Article Type
Display Headline
Using aspirin and ACE inhibitors in combination: Why the hullabaloo?
Display Headline
Using aspirin and ACE inhibitors in combination: Why the hullabaloo?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Anticoagulation therapy in an elderly woman with atrial fibrillation

Article Type
Changed
Fri, 01/25/2019 - 08:24
Display Headline
Anticoagulation therapy in an elderly woman with atrial fibrillation
Article PDF
Author and Disclosure Information

Angela Marschalk, MD
Department of Internal Medicine, Cleveland Clinic

Barbara J. Messinger-Rapport, MD, PhD
Section of Geriatrics, Department of Internal Medicine, Cleveland Clinic

Address: Barbara J. Messinger-Rapport, MD, PhD, Section of Geriatrics, A91, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Issue
Cleveland Clinic Journal of Medicine - 68(6)
Publications
Topics
Page Number
561-566
Sections
Author and Disclosure Information

Angela Marschalk, MD
Department of Internal Medicine, Cleveland Clinic

Barbara J. Messinger-Rapport, MD, PhD
Section of Geriatrics, Department of Internal Medicine, Cleveland Clinic

Address: Barbara J. Messinger-Rapport, MD, PhD, Section of Geriatrics, A91, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Author and Disclosure Information

Angela Marschalk, MD
Department of Internal Medicine, Cleveland Clinic

Barbara J. Messinger-Rapport, MD, PhD
Section of Geriatrics, Department of Internal Medicine, Cleveland Clinic

Address: Barbara J. Messinger-Rapport, MD, PhD, Section of Geriatrics, A91, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 68(6)
Issue
Cleveland Clinic Journal of Medicine - 68(6)
Page Number
561-566
Page Number
561-566
Publications
Publications
Topics
Article Type
Display Headline
Anticoagulation therapy in an elderly woman with atrial fibrillation
Display Headline
Anticoagulation therapy in an elderly woman with atrial fibrillation
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Evidence of smoke and atherosclerotic fire

Article Type
Changed
Fri, 01/25/2019 - 07:34
Display Headline
Evidence of smoke and atherosclerotic fire
Article PDF
Author and Disclosure Information

Brian F. Mandell, MD, PhD
Deputy Editor, Cleveland Clinic Journal of Medicine; Senior Associate Program Director, Internal Medicine Residency Program; Department of Rheumatic Diseases, Cleveland Clinic

Address: Brian F. Mandell, MD, PhD, Cleveland Clinic Journal of Medicine, NA32, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Issue
Cleveland Clinic Journal of Medicine - 68(6)
Publications
Topics
Page Number
538-540
Sections
Author and Disclosure Information

Brian F. Mandell, MD, PhD
Deputy Editor, Cleveland Clinic Journal of Medicine; Senior Associate Program Director, Internal Medicine Residency Program; Department of Rheumatic Diseases, Cleveland Clinic

Address: Brian F. Mandell, MD, PhD, Cleveland Clinic Journal of Medicine, NA32, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Author and Disclosure Information

Brian F. Mandell, MD, PhD
Deputy Editor, Cleveland Clinic Journal of Medicine; Senior Associate Program Director, Internal Medicine Residency Program; Department of Rheumatic Diseases, Cleveland Clinic

Address: Brian F. Mandell, MD, PhD, Cleveland Clinic Journal of Medicine, NA32, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 68(6)
Issue
Cleveland Clinic Journal of Medicine - 68(6)
Page Number
538-540
Page Number
538-540
Publications
Publications
Topics
Article Type
Display Headline
Evidence of smoke and atherosclerotic fire
Display Headline
Evidence of smoke and atherosclerotic fire
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

C-reactive protein: A 'golden marker' for inflammation and coronary artery disease

Article Type
Changed
Fri, 01/25/2019 - 07:08
Display Headline
C-reactive protein: A 'golden marker' for inflammation and coronary artery disease
Article PDF
Author and Disclosure Information

Vasant B. Patel, MD
Mid America Heart Institute, Saint Luke‘s Hospital, Kansas City, MO

Mark A. Robbins, MD
Department of Cardiology, Cleveland Clinic

Eric J. Topol, MD
Chairman, Department of Cardiology, Cleveland Clinic

Address: Vasant B. Patel, MD, Mid America Heart Institute, Saint Luke’s Hospital, 4330 Wornall, Suite 2000, Kansas City, MO 64111; [email protected]

Issue
Cleveland Clinic Journal of Medicine - 68(6)
Publications
Topics
Page Number
521-524, 527-534
Sections
Author and Disclosure Information

Vasant B. Patel, MD
Mid America Heart Institute, Saint Luke‘s Hospital, Kansas City, MO

Mark A. Robbins, MD
Department of Cardiology, Cleveland Clinic

Eric J. Topol, MD
Chairman, Department of Cardiology, Cleveland Clinic

Address: Vasant B. Patel, MD, Mid America Heart Institute, Saint Luke’s Hospital, 4330 Wornall, Suite 2000, Kansas City, MO 64111; [email protected]

Author and Disclosure Information

Vasant B. Patel, MD
Mid America Heart Institute, Saint Luke‘s Hospital, Kansas City, MO

Mark A. Robbins, MD
Department of Cardiology, Cleveland Clinic

Eric J. Topol, MD
Chairman, Department of Cardiology, Cleveland Clinic

Address: Vasant B. Patel, MD, Mid America Heart Institute, Saint Luke’s Hospital, 4330 Wornall, Suite 2000, Kansas City, MO 64111; [email protected]

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 68(6)
Issue
Cleveland Clinic Journal of Medicine - 68(6)
Page Number
521-524, 527-534
Page Number
521-524, 527-534
Publications
Publications
Topics
Article Type
Display Headline
C-reactive protein: A 'golden marker' for inflammation and coronary artery disease
Display Headline
C-reactive protein: A 'golden marker' for inflammation and coronary artery disease
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Is atherosclerosis an infectious disease?

Article Type
Changed
Wed, 01/16/2019 - 08:25
Display Headline
Is atherosclerosis an infectious disease?
Article PDF
Author and Disclosure Information

Steven D. Mawhorter, MD
Department of Infectious Disease, Cleveland Clinic

Michael A. Lauer, MD
Department of Cardiology, Borgess Medical Center Research Institute, Kalamazoo, Michigan

Address: Steven D. Mawhorter, MD, Department of Infectious Disease, S32, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

This paper discusses treatment that is “off label,” ie, not FDA-approved.

Issue
Cleveland Clinic Journal of Medicine - 68(5)
Publications
Topics
Page Number
449-458
Sections
Author and Disclosure Information

Steven D. Mawhorter, MD
Department of Infectious Disease, Cleveland Clinic

Michael A. Lauer, MD
Department of Cardiology, Borgess Medical Center Research Institute, Kalamazoo, Michigan

Address: Steven D. Mawhorter, MD, Department of Infectious Disease, S32, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

This paper discusses treatment that is “off label,” ie, not FDA-approved.

Author and Disclosure Information

Steven D. Mawhorter, MD
Department of Infectious Disease, Cleveland Clinic

Michael A. Lauer, MD
Department of Cardiology, Borgess Medical Center Research Institute, Kalamazoo, Michigan

Address: Steven D. Mawhorter, MD, Department of Infectious Disease, S32, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

This paper discusses treatment that is “off label,” ie, not FDA-approved.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 68(5)
Issue
Cleveland Clinic Journal of Medicine - 68(5)
Page Number
449-458
Page Number
449-458
Publications
Publications
Topics
Article Type
Display Headline
Is atherosclerosis an infectious disease?
Display Headline
Is atherosclerosis an infectious disease?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Coronary artery disease in women: Different, often undertreated

Article Type
Changed
Wed, 01/16/2019 - 08:19
Display Headline
Coronary artery disease in women: Different, often undertreated
Article PDF
Author and Disclosure Information

Hani Jneid, MD
Department of Internal Medicine, Cleveland Clinic

Holly L. Thacker, MD, FACP
Head, Section of Women’s Health, Departments of General Internal Medicine and Obstetrics and Gynecology, Cleveland Clinic; Director of Women’s Health Track GIM Fellowship, Clinical Associate Professor of Medicine, Penn State University

Address: Holly L. Thacker, MD, FACP, Department of General Internal Medicine and Obstetrics and Gynecology, A91, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195;
[email protected]

This paper discusses treatment information that is “off-label,” ie, not approved by the Food and Drug Administration for the indication under discussion.

Issue
Cleveland Clinic Journal of Medicine - 68(5)
Publications
Topics
Page Number
441-448
Sections
Author and Disclosure Information

Hani Jneid, MD
Department of Internal Medicine, Cleveland Clinic

Holly L. Thacker, MD, FACP
Head, Section of Women’s Health, Departments of General Internal Medicine and Obstetrics and Gynecology, Cleveland Clinic; Director of Women’s Health Track GIM Fellowship, Clinical Associate Professor of Medicine, Penn State University

Address: Holly L. Thacker, MD, FACP, Department of General Internal Medicine and Obstetrics and Gynecology, A91, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195;
[email protected]

This paper discusses treatment information that is “off-label,” ie, not approved by the Food and Drug Administration for the indication under discussion.

Author and Disclosure Information

Hani Jneid, MD
Department of Internal Medicine, Cleveland Clinic

Holly L. Thacker, MD, FACP
Head, Section of Women’s Health, Departments of General Internal Medicine and Obstetrics and Gynecology, Cleveland Clinic; Director of Women’s Health Track GIM Fellowship, Clinical Associate Professor of Medicine, Penn State University

Address: Holly L. Thacker, MD, FACP, Department of General Internal Medicine and Obstetrics and Gynecology, A91, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195;
[email protected]

This paper discusses treatment information that is “off-label,” ie, not approved by the Food and Drug Administration for the indication under discussion.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 68(5)
Issue
Cleveland Clinic Journal of Medicine - 68(5)
Page Number
441-448
Page Number
441-448
Publications
Publications
Topics
Article Type
Display Headline
Coronary artery disease in women: Different, often undertreated
Display Headline
Coronary artery disease in women: Different, often undertreated
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Safe use of sildenafil in patients with coronary artery disease

Article Type
Changed
Mon, 03/04/2019 - 08:22
Display Headline
Safe use of sildenafil in patients with coronary artery disease
Article PDF
Author and Disclosure Information

Howard S. Bush, MD, FACC
Chairman, Department of Cardiology, Cleveland Clinic Florida, Fort Lauderdale

Address: Howard S. Bush, MD, FACC, Chairman, Department of Cardiology, Cleveland Clinic Florida, 3000 West Cypress Creek Road, Fort Lauderdale, FL 33309; [email protected]

Issue
Cleveland Clinic Journal of Medicine - 68(4)
Publications
Topics
Page Number
349, 352
Sections
Author and Disclosure Information

Howard S. Bush, MD, FACC
Chairman, Department of Cardiology, Cleveland Clinic Florida, Fort Lauderdale

Address: Howard S. Bush, MD, FACC, Chairman, Department of Cardiology, Cleveland Clinic Florida, 3000 West Cypress Creek Road, Fort Lauderdale, FL 33309; [email protected]

Author and Disclosure Information

Howard S. Bush, MD, FACC
Chairman, Department of Cardiology, Cleveland Clinic Florida, Fort Lauderdale

Address: Howard S. Bush, MD, FACC, Chairman, Department of Cardiology, Cleveland Clinic Florida, 3000 West Cypress Creek Road, Fort Lauderdale, FL 33309; [email protected]

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 68(4)
Issue
Cleveland Clinic Journal of Medicine - 68(4)
Page Number
349, 352
Page Number
349, 352
Publications
Publications
Topics
Article Type
Display Headline
Safe use of sildenafil in patients with coronary artery disease
Display Headline
Safe use of sildenafil in patients with coronary artery disease
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

Should an ACE inhibitor be stopped if signs of renal insufficiency appear?

Article Type
Changed
Tue, 05/03/2022 - 16:11
Display Headline
Should an ACE inhibitor be stopped if signs of renal insufficiency appear?
Article PDF
Author and Disclosure Information

Alejandro Morales, MD
Department of Medicine, Cleveland Clinic

Vincent W. Dennis, MD
Chairman, Department of Nephrology and Hypertension, Cleveland Clinic

Address: Vincent W. Dennis, MD, Department of Nephrology and Hypertension, A51,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Issue
Cleveland Clinic Journal of Medicine - 68(4)
Publications
Topics
Page Number
280, 282
Sections
Author and Disclosure Information

Alejandro Morales, MD
Department of Medicine, Cleveland Clinic

Vincent W. Dennis, MD
Chairman, Department of Nephrology and Hypertension, Cleveland Clinic

Address: Vincent W. Dennis, MD, Department of Nephrology and Hypertension, A51,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Author and Disclosure Information

Alejandro Morales, MD
Department of Medicine, Cleveland Clinic

Vincent W. Dennis, MD
Chairman, Department of Nephrology and Hypertension, Cleveland Clinic

Address: Vincent W. Dennis, MD, Department of Nephrology and Hypertension, A51,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 68(4)
Issue
Cleveland Clinic Journal of Medicine - 68(4)
Page Number
280, 282
Page Number
280, 282
Publications
Publications
Topics
Article Type
Display Headline
Should an ACE inhibitor be stopped if signs of renal insufficiency appear?
Display Headline
Should an ACE inhibitor be stopped if signs of renal insufficiency appear?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

Should patients with documented or probable coronary artery disease routinely be placed on beta-blockers before noncardiac surgery?

Article Type
Changed
Fri, 03/01/2019 - 09:19
Display Headline
Should patients with documented or probable coronary artery disease routinely be placed on beta-blockers before noncardiac surgery?
Article PDF
Author and Disclosure Information

J. Harry Isaacson, MD
Director of Education Programs and Vice-Chairman, Department of General Internal Medicine, Cleveland Clinic

Address: J. Harry Isaacson, MD, Department of General Internal Medicine, A91, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Issue
Cleveland Clinic Journal of Medicine - 68(4)
Publications
Topics
Page Number
273-274
Sections
Author and Disclosure Information

J. Harry Isaacson, MD
Director of Education Programs and Vice-Chairman, Department of General Internal Medicine, Cleveland Clinic

Address: J. Harry Isaacson, MD, Department of General Internal Medicine, A91, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Author and Disclosure Information

J. Harry Isaacson, MD
Director of Education Programs and Vice-Chairman, Department of General Internal Medicine, Cleveland Clinic

Address: J. Harry Isaacson, MD, Department of General Internal Medicine, A91, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 68(4)
Issue
Cleveland Clinic Journal of Medicine - 68(4)
Page Number
273-274
Page Number
273-274
Publications
Publications
Topics
Article Type
Display Headline
Should patients with documented or probable coronary artery disease routinely be placed on beta-blockers before noncardiac surgery?
Display Headline
Should patients with documented or probable coronary artery disease routinely be placed on beta-blockers before noncardiac surgery?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

Management of asymptomatic left ventricular dysfunction

Article Type
Changed
Mon, 01/14/2019 - 10:43
Display Headline
Management of asymptomatic left ventricular dysfunction
Article PDF
Author and Disclosure Information

Garrie J. Haas, MD
The Kaufman Center for Heart Failure, Department of Cardiology, Cleveland Clinic

Address: Garrie J. Haas, MD, Section of Heart Failure and Cardiac Transplant Medicine, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Issue
Cleveland Clinic Journal of Medicine - 68(3)
Publications
Topics
Page Number
249-255
Sections
Author and Disclosure Information

Garrie J. Haas, MD
The Kaufman Center for Heart Failure, Department of Cardiology, Cleveland Clinic

Address: Garrie J. Haas, MD, Section of Heart Failure and Cardiac Transplant Medicine, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Author and Disclosure Information

Garrie J. Haas, MD
The Kaufman Center for Heart Failure, Department of Cardiology, Cleveland Clinic

Address: Garrie J. Haas, MD, Section of Heart Failure and Cardiac Transplant Medicine, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 68(3)
Issue
Cleveland Clinic Journal of Medicine - 68(3)
Page Number
249-255
Page Number
249-255
Publications
Publications
Topics
Article Type
Display Headline
Management of asymptomatic left ventricular dysfunction
Display Headline
Management of asymptomatic left ventricular dysfunction
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media